ZA969139B - Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans. - Google Patents
Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans.Info
- Publication number
- ZA969139B ZA969139B ZA9609139A ZA969139A ZA969139B ZA 969139 B ZA969139 B ZA 969139B ZA 9609139 A ZA9609139 A ZA 9609139A ZA 969139 A ZA969139 A ZA 969139A ZA 969139 B ZA969139 B ZA 969139B
- Authority
- ZA
- South Africa
- Prior art keywords
- zeaxanthin
- stereoisomer
- humans
- pure
- macular degeneration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/551,153 US5827652A (en) | 1995-10-31 | 1995-10-31 | Zeaxanthin formulations for human ingestion |
US08/551,166 US5854015A (en) | 1995-10-31 | 1995-10-31 | Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA969139B true ZA969139B (en) | 1997-09-25 |
Family
ID=27069666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9609139A ZA969139B (en) | 1995-10-31 | 1996-10-30 | Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans. |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPH10512594A (sv) |
KR (1) | KR100570251B1 (sv) |
CN (1) | CN1104235C (sv) |
AR (1) | AR004245A1 (sv) |
AU (1) | AU710634B2 (sv) |
BR (1) | BR9611488A (sv) |
CZ (1) | CZ297575B6 (sv) |
FI (1) | FI980947A (sv) |
HU (1) | HU223208B1 (sv) |
NO (1) | NO981698L (sv) |
PL (1) | PL185465B1 (sv) |
RU (1) | RU2197958C2 (sv) |
WO (1) | WO1997016175A1 (sv) |
ZA (1) | ZA969139B (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8088363B2 (en) | 2002-10-28 | 2012-01-03 | Zeavision Llc | Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin |
GB0501365D0 (en) | 2005-01-21 | 2005-03-02 | Promar As | Compositions |
US20060185034A1 (en) * | 2005-02-11 | 2006-08-17 | Kalamazoo Holdings, Inc. | Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
US8592662B2 (en) | 2005-02-11 | 2013-11-26 | Kalamazoo Holdings, Inc. | Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US308759A (en) * | 1884-12-02 | Curling hat-brims and machine therefor | ||
KR0148133B1 (ko) * | 1989-08-30 | 1998-08-01 | 엘. 기르하르트 데니스 | 제아키산틴의 제조 및 제아키산틴 함유 조성물 |
US5310764A (en) * | 1992-05-08 | 1994-05-10 | Steven Baranowitz | Treatment of age related macular degeneration with beta-carotene |
-
1996
- 1996-10-30 PL PL96326558A patent/PL185465B1/pl unknown
- 1996-10-30 CZ CZ0130998A patent/CZ297575B6/cs not_active IP Right Cessation
- 1996-10-30 ZA ZA9609139A patent/ZA969139B/xx unknown
- 1996-10-30 BR BR9611488A patent/BR9611488A/pt not_active Application Discontinuation
- 1996-10-30 JP JP9517583A patent/JPH10512594A/ja active Pending
- 1996-10-30 KR KR1019980703131A patent/KR100570251B1/ko not_active IP Right Cessation
- 1996-10-30 HU HU9802314A patent/HU223208B1/hu not_active IP Right Cessation
- 1996-10-30 CN CN96198014A patent/CN1104235C/zh not_active Expired - Fee Related
- 1996-10-30 WO PCT/US1996/017563 patent/WO1997016175A1/en active IP Right Grant
- 1996-10-30 RU RU98110058/14A patent/RU2197958C2/ru not_active IP Right Cessation
- 1996-10-30 AU AU70501/96A patent/AU710634B2/en not_active Ceased
- 1996-10-31 AR ARP960104982A patent/AR004245A1/es unknown
-
1998
- 1998-04-16 NO NO981698A patent/NO981698L/no not_active Application Discontinuation
- 1998-04-29 FI FI980947A patent/FI980947A/sv not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1104235C (zh) | 2003-04-02 |
WO1997016175A1 (en) | 1997-05-09 |
RU2197958C2 (ru) | 2003-02-10 |
KR19990067180A (ko) | 1999-08-16 |
MX9605248A (es) | 1998-06-30 |
CZ130998A3 (cs) | 1998-07-15 |
KR100570251B1 (ko) | 2006-06-21 |
PL326558A1 (en) | 1998-09-28 |
FI980947A (sv) | 1998-04-29 |
JPH10512594A (ja) | 1998-12-02 |
CN1201388A (zh) | 1998-12-09 |
HU223208B1 (hu) | 2004-03-29 |
PL185465B1 (pl) | 2003-05-30 |
CZ297575B6 (cs) | 2007-02-07 |
AR004245A1 (es) | 1998-11-04 |
HUP9802314A3 (en) | 1999-05-28 |
BR9611488A (pt) | 1999-01-19 |
NO981698D0 (no) | 1998-04-16 |
HUP9802314A2 (hu) | 1999-04-28 |
AU710634B2 (en) | 1999-09-23 |
NO981698L (no) | 1998-06-08 |
AU7050196A (en) | 1997-05-08 |
FI980947A0 (sv) | 1996-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL117793A0 (en) | Method for the treatment of macular degeneration | |
AU5499896A (en) | Hair treatment compositions | |
ZA96740B (en) | Skin treatment composition | |
AU4104896A (en) | Stable lycopene concentrates and process for their preparation | |
ZA966240B (en) | Methods for treatment of allergic asthma. | |
IL116935A0 (en) | Venlafaxine for the treatment of hypothalmic amenorrhea | |
AU6522396A (en) | Composition for cleaning or treating human or animal hair | |
AU4776096A (en) | Whey treatment process | |
AU4792396A (en) | Process for the preparation of ethyl-N-(2,3 dichloro-6- nitrobenzyl) glycine | |
AU3584895A (en) | Method of treating macular degeneration using tgf-beta | |
AU2825295A (en) | Method for the treatment, prevention or minimization of hair loss | |
AU3768795A (en) | Method and compositions for hair treatment | |
SG60050A1 (en) | Process for the preparation of enantiomerically pure cyclo-alkanl-indol-and azaindol-and pyrimido(1,2a) indol-carbocylic acids and their activated derivatives | |
ZA969139B (en) | Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans. | |
GR3031738T3 (en) | Process for the preparation of 1,1-difluoroethane | |
AU4729396A (en) | Process for the preparation of 1,2-benzisothiazolin-3-ones | |
AU2068295A (en) | Skin treatment composition | |
AU3137095A (en) | Ophthalmic compositions for treating glaucoma | |
AUPN499895A0 (en) | Hair treatment composition | |
AU7729096A (en) | Oligodendrocyte-specific protein and method for treating disease | |
IL125004A0 (en) | Process for the preparation of 9,11 beta-epoxide steroids | |
AU697136B2 (en) | Agents for treating metabolic bone diseases | |
AU6662794A (en) | Composition for the treatment of impaired hair growth | |
IL118731A0 (en) | Process for the preparation of 2,2-dialkyl-arylidene-cycloalkanones | |
WO1993006813A3 (en) | Hair treatment composition |